Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer
详细信息 查看全文
- 作者：Tomoo Inoue ; Toshio Nishi ; Yoshiaki Nakano ; Ayaka Nishimae ; Yuka Sawai…
- 关键词：Breast cancer ; Sentinel lymph node biopsy ; Indocyanine green ; Fluorescence ; Patent blue
- 刊名：Breast Cancer
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：23
- 期：2
- 页码：295-300
- 全文大小：519 KB
- 参考文献：1.Saji S, Hiraoka M, Tokuda Y, Fukui N, Ikeda T. Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004–2009. Breast Cancer. 2012;19:1–3.CrossRef PubMed
2.Rutgers EJ. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol. 2008;26:698–702.CrossRef PubMed
3.Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whiworth PW, Blumencranz P, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.CrossRef PubMed
4.Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32:1365–83.CrossRef PubMed
5.Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, et al. A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat. 2000;63:31–40.CrossRef PubMed
6.Cody HS 3rd, Fey J, Akhurst T, Fazzari M, Mazumdar M, Yeung H, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol. 2001;8:13–9.CrossRef PubMed
7.Goyal A, Newcomb RG, Chhabra A, Mansel RE, ALMANAC Trialists Group. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer–results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203–8.CrossRef PubMed
8.Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4–16.CrossRef PubMed
9.Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211–5.CrossRef PubMed
10.Hirano A, Kamimura M, Ogura K, Kim N, Hattori A, Setoguchi Y, et al. A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients. Ann Surg Oncol. 2012;19:4112–6.CrossRef PubMed
11.Schaafsma BE, Verbeek FP, Rietbergen DD, van der Hiel B, van der Vorst JR, Liefers GJ, et al. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg. 2013;100:1037–44.CrossRef PubMed PubMedCentral
12.Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K, Toi M, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2013;20:2213–8.CrossRef PubMed
13.Jung SY, Kim SK, Kim SW, Kwon Y, Lee ES, Kang HS, et al. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial. Ann Surg Oncol. 2014;21:1254–9.CrossRef PubMed
14.Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S, Koyama H. Sentinel node biopsy guided by indocyanin green dye in breast cancer patients. Jpn J Clin Oncol. 1999;29:604–7.CrossRef PubMed
15.Ballardini B, Santoro L, Sangalli C, Gentilini O, Renne G, Lissidini G, et al. The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. Eur J Surg Oncol. 2013;39:1332–6.CrossRef PubMed
16.Motomura K, Inaji H, Komoike Y, Hasegawa Y, Noguchi S, Koyama H, et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol. 2001;76:95–9.CrossRef PubMed
17.Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19:210–3.CrossRef PubMed
18.Wishart GC, Loh SW, Jones L, Benson JR. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol. 2012;38:651–6.CrossRef PubMed
19.Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA, Cox CE, et al. Factors associated with local-regional recurrence after a negative sentinel node dissection: result of the ACOSOG Z0010 trial. Ann Surg. 2012;256:428–36.CrossRef PubMed
20.Schlembach PJ, Buchholz TA, Ross MI, Kirsner SM, Salas GJ, Strom EA. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001;51:671–8.CrossRef PubMed - 作者单位：Tomoo Inoue (1)
Toshio Nishi (1)
Yoshiaki Nakano (1)
Ayaka Nishimae (1)
Yuka Sawai (2)
Masaru Yamasaki (3)
Hideo Inaji (1)
1. Department of Breast Surgery, Kaizuka City Hospital, 3-10-20, Hori, Kaizuka, Osaka, 597-0015, Japan
2. Department of Diagnostic Radiology, Kaizuka City Hospital, Kaizuka, Osaka, Japan
3. Department of Pathology, Kaizuka City Hospital, Kaizuka, Osaka, Japan - 刊物主题：Surgical Oncology; Oncology; Surgery; Cancer Research;
- 出版者：Springer Japan
- ISSN：1880-4233
文摘
Background There is limited information on indocyanine green (ICG) fluorescence and blue dye for detecting sentinel lymph node (SLN) in early breast cancer. A retrospective study was conducted to assess the feasibility of an SLN biopsy using the combination of ICG fluorescence and the blue dye method.